Manageable Anemia Achieved With Magrolimab Plus Azacitidine in High-Risk MDS/AML - Cancer Network

Combining magrolimab with azacitidine led to manageable anemia in patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia.

Attaining manageable anemia was possible for patients with higher-risk myelodysplastic syndrome (HR-MDS) and acute myeloid leukemia (AML) who were treated with priming and maintenance doses of magrol… [+4053 chars]

full article...